{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T13:02:06Z","timestamp":1770814926957,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Problems in Cardiology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.cpcardiol.2024.102739","type":"journal-article","created":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T00:43:20Z","timestamp":1720226600000},"page":"102739","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["A Closer Look into Gastrointestinal Bleeding in Heart Failure Patients"],"prefix":"10.1016","volume":"49","author":[{"given":"Anas","family":"Zaher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jude","family":"ElSaygh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akram","family":"Midani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Treihaft","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brinda","family":"Banerji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammed Fouad","family":"Bouso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malik","family":"Mushannen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rawan","family":"Hussein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carl V.","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.cpcardiol.2024.102739_bib0001","first-page":"227","article-title":"Gastrointestinal complications in critically ill patients: the intensivists\u2019 overview","volume":"81","author":"Gottlieb","year":"1986","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cpcardiol.2024.102739_bib0002","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","article-title":"Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation","volume":"146","author":"Hart","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cpcardiol.2024.102739_bib0003","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1161\/CIRCIMAGING.113.000633","article-title":"Cardiac magnetic resonance postcontrast T1 time is associated with outcome in patients with heart failure and preserved ejection fraction","volume":"6","author":"Mascherbauer","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.cpcardiol.2024.102739_bib0004","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J"},{"issue":"22","key":"10.1016\/j.cpcardiol.2024.102739_bib0005","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1093\/eurheartj\/ehs274","article-title":"Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial","volume":"33","author":"Hohnloser","year":"2012","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.cpcardiol.2024.102739_bib0006","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2015.05.002","article-title":"Prevention of dabigatran-related gastrointestinal bleeding with gastroprotective agents: a population-based study","volume":"149","author":"Chan","year":"2015","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.cpcardiol.2024.102739_bib0007","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1161\/CIRCULATIONAHA.108.801753","article-title":"Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) trial","volume":"119","author":"Massie","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2024.102739_bib0008","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro heart survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.cpcardiol.2024.102739_bib0009","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"issue":"21","key":"10.1016\/j.cpcardiol.2024.102739_bib0010","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1161\/CIRCULATIONAHA.110.004747","article-title":"Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial","volume":"123","author":"Eikelboom","year":"2011","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.cpcardiol.2024.102739_bib0011","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1124\/dmd.107.019083","article-title":"The metabolism and disposition of the oral direct thrombin inhibitor, dabigatran, in humans","volume":"36","author":"Blech","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.cpcardiol.2024.102739_bib0012","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1055\/s-0038-1675400","article-title":"Predicting thromboembolic and bleeding event risk in patients with non-valvular atrial fibrillation: a systematic review","volume":"118","author":"Borre","year":"2018","journal-title":"Thromb Haemost"},{"issue":"6","key":"10.1016\/j.cpcardiol.2024.102739_bib0013","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1002\/ejhf.1153","article-title":"Anticoagulation in heart failure without atrial fibrillation: gaps and dilemmas in current clinical practice","volume":"20","author":"Siliste","year":"2018","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"10.1016\/j.cpcardiol.2024.102739_bib0014","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1016\/S2352-3026(15)00249-5","article-title":"Risk of venous thromboembolism in patients with heart failure","volume":"3","author":"Larsen","year":"2016","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.cpcardiol.2024.102739_bib0015","doi-asserted-by":"crossref","DOI":"10.1097\/CRD.0000000000000534","article-title":"Back up at the pump? I have a gut feeling about this: a review of the gastrointestinal manifestations from congestive heart failure","author":"Yee","year":"2023","journal-title":"Cardiol Rev"},{"issue":"6","key":"10.1016\/j.cpcardiol.2024.102739_bib0016","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.hlc.2015.11.010","article-title":"Thrombocytopaenia as a prognostic indicator in heart failure with reduced ejection fraction","volume":"25","author":"Mojadidi","year":"2016","journal-title":"Heart Lung Circ"},{"issue":"1","key":"10.1016\/j.cpcardiol.2024.102739_bib0017","doi-asserted-by":"crossref","first-page":"86","DOI":"10.4291\/wjgp.v7.i1.86","article-title":"Upper gastrointestinal bleeding risk scores: who, when and why?","volume":"7","author":"Monteiro","year":"2016","journal-title":"World J Gastrointest Pathophysiol"},{"issue":"1","key":"10.1016\/j.cpcardiol.2024.102739_bib0018","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jjcc.2022.02.003","article-title":"B-type natriuretic peptide is associated with the occurrence of bleeding events in heart failure patients with a history of coronary artery disease","volume":"80","author":"Sato","year":"2022","journal-title":"J Cardiol"},{"key":"10.1016\/j.cpcardiol.2024.102739_bib0019","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s00134-015-3725-1","article-title":"Prevalence and outcome of gastrointestinal bleeding and use of acid suppressants in acutely ill adult intensive care patients","volume":"41","author":"Krag","year":"2015","journal-title":"Intensive Care Med"},{"issue":"2","key":"10.1016\/j.cpcardiol.2024.102739_bib0020","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jacc.2021.10.028","article-title":"Magnetically controlled capsule endoscopy for assessment of antiplatelet therapy-induced gastrointestinal injury","volume":"79","author":"Han","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.cpcardiol.2024.102739_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2011.05.020","article-title":"Low doses of acetylsalicylic acid increase risk of gastrointestinal bleeding in a meta-analysis","volume":"9","author":"Lanas","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"9684","key":"10.1016\/j.cpcardiol.2024.102739_bib0022","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0140-6736(09)61246-0","article-title":"Famotidine for the prevention of peptic ulcers and oesophagitis in patients taking low-dose aspirin (FAMOUS): a phase III, randomised, double-blind, placebo-controlled trial","volume":"374","author":"Taha","year":"2009","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.cpcardiol.2024.102739_bib0023","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1001\/jama.2009.261","article-title":"Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome","volume":"301","author":"Ho","year":"2009","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.cpcardiol.2024.102739_bib0024","doi-asserted-by":"crossref","first-page":"334","DOI":"10.5056\/jnm18029","article-title":"Potent potassium-competitive acid blockers: a new era for the treatment of acid-related diseases","volume":"24","author":"Oshima","year":"2018","journal-title":"J Neurogastroenterol Motil"},{"issue":"8","key":"10.1016\/j.cpcardiol.2024.102739_bib0025","doi-asserted-by":"crossref","first-page":"897","DOI":"10.3390\/metabo13080897","article-title":"Pharmacokinetic and pharmacodynamic drug-drug interactions: research methods and applications","volume":"13","author":"Sun","year":"2023","journal-title":"Metabolites"}],"container-title":["Current Problems in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280624003761?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280624003761?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,28]],"date-time":"2024-07-28T05:48:10Z","timestamp":1722145690000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0146280624003761"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":25,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S0146280624003761"],"URL":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2024.102739","relation":{},"ISSN":["0146-2806"],"issn-type":[{"value":"0146-2806","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Closer Look into Gastrointestinal Bleeding in Heart Failure Patients","name":"articletitle","label":"Article Title"},{"value":"Current Problems in Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2024.102739","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102739"}}